There was a positive correlation between SOD levels and the Expanded Disability Status Scale (EDSS) score both before and after melatonin treatment [109], indicating the importance of antioxidant protection in controlling disability in MS. The gene discussed is SOD1; the disease is myeloid sarcoma.